The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.

Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a progressive neurological disease with an ...

For decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...

Unexpected mutations in blood stem cells may help protect against Alzheimer’s disease. A new study published in the journal ...

In a paper published last month, researchers at UT Southwestern Medical Center introduced lipid nanoparticles — hollow, fatty ...

Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.

A groundbreaking study led by Prof. Bo Peng at Fudan University demonstrates that microglia replacement effectively halts the ...

Early fallopian tube cell changes were found in a high‑risk patient. A live tissue bank and organoid system will help explore ...

DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

Scientists have uncovered DNA from 214 ancient pathogens in prehistoric humans, including the oldest known evidence of plague ...